Avanos Medical, Inc

Avanos is headquartered in Alpharetta, Georgia and manufactures in the United States, Mexico, and Canada. Its distribution network spans North America, Europe, Australia, and Japan, which supports global commercialization of its medical device portfolio. North America is the largest revenue region, while Europe, the Middle East and Africa and Asia Pacific/Latin America provide additional international exposure. The company also relies on distributors more heavily outside North America, making regional channel structure and reimbursement conditions important to growth and margin performance. Portfolio changes and manufacturing footprint optimization are part of its transformation plan, so geography matters both for supply chain efficiency and for where the company can sell directly versus through partners.

Avanos operates in a highly competitive medical device market where price, clinical alternatives, innovation, and reputation all affect share. Its products are exposed to product liability claims, recalls, safety alerts, and regulatory actions because they are used in invasive or procedure-related settings. Reimbursement pressure from government programs and private insurers can reduce customer willingness to pay and can force pricing concessions, especially in cost-sensitive healthcare systems. The company also faces execution risk from its ongoing transformation, including divestitures, restructuring, and manufacturing footprint changes, which can disrupt supply or distract management. In addition, tariffs, foreign exchange, distributor concentration, and international channel dependence can affect margins and demand across regions.